Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-09

FDA Approved: ESCITALOPRAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Escitalopram oxalate (escitalopram) from Sun Pharmaceutical Industries, authorizing its marketing as a generic in th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITALOPRAM OXALATE)